Concepedia

Publication | Open Access

The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy

DOIFull Paper Access

80

Citations

23

References

2012

Year

Jason R. Andrews, Stephen D Lawn, Corina Rusu, Robin Wood, Farzad Noubary, Melissa A. Bender, C. Robert Horsburgh, Elena Losina, Kenneth A. Freedberg, Rochelle P. Walensky
AIDS

Abstract

Model-based analysis suggests that screening all individuals initiating ART in South Africa with two Xpert samples is very cost-effective.

References

YearCitations

Page 1